Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Feb 24, 2021 8:53am
274 Views
Post# 32645177

RE:Close at the high

RE:Close at the highI have a feeling that today will be even stronger than Tuesday.
there was a nice spike at close indicating as westcoast mentioned a strong technical indicator.
in addition, lining up the recent activities 
4 weeks ago there was a $3million institution buy, 
a recent $ 15 ps recommendation.
the NR Tuesday, for the first time EVER IN ONC HISTORY, used the word CURE
the results of that study were a side project,meaning not even on the list of expected milestones up & coming.
there will be a short squeeze, a mathematical fact. The crash at open yesterday was probably shorts.
they will be hurting & have to cover.
seeing the massive NAS a volume will attract a lot of attention.
All good things...
snd Q4 cc coming in about 2 weeks.
all arrows pointing up...enjoy
<< Previous
Bullboard Posts
Next >>